Harvard Apparatus Regenerative Technology, Inc. (HRGN)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Annual

0 250K 500K 750K FY12: 0 FY13: 22K FY14: 93K FY15: 118K FY16: 82K FY17: 0 FY18: 0 FY19: 0 FY20: 0 FY21: 0 FY23: 103K FY24: 430K FY25: 704K FY12 FY14 FY16 FY18 FY20 FY23 FY25

Gross Profit Annual

-40K -20K 0 20K 40K 60K FY12: 0 FY13: 11K FY14: 45K FY15: -21K FY16: -34K FY17: 0 FY12 FY13 FY14 FY15 FY16 FY17

Operating Income Annual

-15M -10M -5M 0 5M 10M 15M FY12: -6.7M FY13: -8.8M FY14: -11.1M FY15: -11.7M FY16: -12.1M FY17: -11.5M FY18: -7.8M FY19: -8.9M FY20: -5.3M FY21: -8.6M FY22: -6.2M FY23: -9M FY24: -7.7M FY25: -6.9M FY13 FY15 FY17 FY19 FY21 FY23 FY25

Net Income Annual

-15M -10M -5M 0 5M 10M 15M FY12: -6.7M FY13: -8.8M FY14: -11.1M FY15: -11.7M FY16: -11.6M FY17: -11.9M FY18: -7.5M FY19: -8.3M FY20: -4.9M FY21: -8M FY22: -6.1M FY23: -8.9M FY24: -7.7M FY25: -6.9M FY13 FY15 FY17 FY19 FY21 FY23 FY25

Cost of Revenue Annual

0 250K 500K 750K FY12: 0 FY13: 11K FY14: 48K FY15: 139K FY16: 116K FY17: 0 FY23: 24K FY24: 270K FY25: 646K FY12 FY13 FY14 FY15 FY16 FY17 FY23 FY24 FY25

Operating Cash Flow Annual

-12M -8M -4M 0 4M 8M 12M FY12: -5.9M FY13: -7.7M FY14: -8M FY15: -7.2M FY16: -9.1M FY17: -11M FY18: -7.6M FY19: -6.1M FY20: -4M FY21: -2.6M FY22: -5.1M FY23: -6.9M FY24: -4.9M FY25: -3.8M FY13 FY15 FY17 FY19 FY21 FY23 FY25

Free Cash Flow Annual

-12M -8M -4M 0 4M 8M 12M FY12: -6.2M FY13: -8M FY14: -9.2M FY15: -7.4M FY16: -9.4M FY17: -11.2M FY18: -7.8M FY19: -6.2M FY20: -4M FY21: -2.6M FY22: -5.1M FY23: -7M FY24: -4.9M FY12 FY14 FY16 FY18 FY20 FY22 FY24

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 6M 12M 18M FY20: 8.8M FY21: 10.1M FY22: 11.3M FY23: 13.5M FY24: 14.8M FY25: 16.5M FY20 FY21 FY22 FY23 FY24 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-12.00 -8.00 -4.00 0.00 4.00 8.00 12.00 Q4 '12: -0.86 Q1 '13: -0.96 Q2 '13: -1.00 Q3 '13: -1.05 Q4 '13: -1.14 Q1 '14: -1.27 Q2 '14: -1.32 Q3 '14: -1.39 Q4 '14: -1.41 Q1 '15: -1.41 Q2 '15: -1.53 Q3 '15: -1.38 Q4 '15: -1.19 Q1 '16: -0.98 Q2 '16: -0.71 Q3 '16: -0.70 Q4 '16: -4.44 Q1 '17: -7.09 Q2 '17: -8.86 Q3 '17: -10.34 Q4 '17: -7.04 Q1 '18: -4.77 Q2 '18: -3.38 Q3 '18: -2.09 Q4 '18: -1.77 Q1 '19: -1.53 Q2 '19: -1.35 Q3 '19: -1.31 Q4 '19: -1.21 Q1 '20: -1.13 Q2 '20: -0.90 Q3 '21: -0.31 Q4 '21: -0.78 Q1 '22: -0.89 Q2 '22: -0.97 Q3 '22: -0.99 Q4 '22: -0.55 Q1 '23: -0.59 Q2 '23: -0.66 Q3 '23: -0.68 Q4 '23: -0.68 Q1 '24: -0.59 Q2 '24: -0.58 Q3 '24: -0.58 Q4 '24: -0.53 Q1 '25: -0.48 Q2 '25: -0.41 Q3 '25: -0.39 Q4 '25: -0.41 Q1 '26: -0.40 Q2 '26: -0.39 Q1 '13 Q4 '14 Q3 '16 Q2 '18 Q1 '20 Q4 '22 Q3 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.